Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

SIRI Levels Following PENG Block in Hip Arthroplasty

3 novembre 2026 aggiornato da: Poznan University of Medical Sciences

Il Blocco del Gruppo Nervoso Pericapsulare Mitiga lo Stress Chirurgico e Migliora l'Analgesia nell'Artroplastica Totale dell'Anca: Uno Studio Randomizzato Controllato

This randomized controlled trial evaluates the effect of ultrasound-guided Pericapsular Nerve Group (PENG) block on the Systemic Inflammation Response Index (SIRI) in elderly patients undergoing total hip arthroplasty under spinal anesthesia. SIRI, calculated as neutrophil count × monocyte count / lymphocyte count, is used as a composite marker of perioperative inflammatory response. The study investigates whether PENG block attenuates the systemic inflammatory reaction to surgical trauma compared to sham block. The study investigates whether PENG block attenuates the systemic inflammatory reaction to surgical trauma compared to sham block.

Panoramica dello studio

Descrizione dettagliata

Surgical trauma induces a systemic inflammatory response characterized by neutrophilia, lymphopenia, and platelet activation. These hematologic alterations reflect the interaction between innate immune activation, stress-induced immunosuppression, and pro-thrombotic mechanisms. The modulation of this response may influence postoperative recovery and complication risk.

The Systemic Inflammation Response Index (SIRI) is calculated as neutrophil count × monocyte count / lymphocyte count. It incorporates neutrophils and monocytes in relation to lymphocytes as a composite marker of systemic inflammation. This study evaluates whether PENG block influences postoperative SIRI in patients undergoing total hip arthroplasty.

The primary objective of this study is to compare SIRI at 12 hours after surgery between the PENG block and sham block groups in elderly patients undergoing total hip arthroplasty under spinal anesthesia.

Peripheral venous blood samples will be collected preoperatively and at 12, 24, and 48 hours after surgery. The primary endpoint is SIRI at 12 hours after surgery.

This study aims to determine whether motor-sparing regional anesthesia may modulate systemic inflammatory response beyond analgesic effects, potentially contributing to improved perioperative outcomes.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Poznan, Polonia, 62-701
        • Poznan University of Medical Sciences

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 65 anni a 100 anni (Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Patients with ASA classification I-III
  • Aged 65-100 years
  • Who will be scheduled for hip arthroplasty under spinal anesthesia

Exclusion Criteria:

  • Patients who have a history of bleeding diathesis
  • Take anticoagulant therapy
  • History of chronic pain before surgery
  • Multiple trauma
  • patients unable to assess their pain (dementia)
  • patients operated under general anesthesia
  • patients having an infection in the region of the procedure
  • the patient who does not accept the procedure

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Quadruplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore fittizio: Sham blocks

PENG block with 20ml of 0.9% sodium chloride

After spinal anesthesia, the ultrasound-guided PENG block will be performed with 20ml of 0.9% sodium chloride

Altri nomi:
  • Iniezione di cloruro di sodio allo 0,9%.
Comparatore attivo: PENG block

PENG block with 20ml 0f 0.2% ropivacaine

After spinal anesthesia, the ultrasound-guided PENG block will be performed with 20 ml of 0.2% ropivacaine

Altri nomi:
  • 0,2% ropivacaina

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Systemic Inflammation Response Index (SIRI)
Lasso di tempo: 12 hours after surgery

Systemic Inflammation Response Index (SIRI) is used as a composite marker of systemic inflammatory activation. It is calculated from peripheral venous blood samples using the formula:

SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count All parameters are obtained from routine complete blood count (CBC) analysis and expressed in ×10⁹/L.

SIRI reflects the interaction between innate immune activation (neutrophils and monocytes) and adaptive immune suppression (lymphocytes). Higher SIRI values indicate greater systemic inflammatory response.

12 hours after surgery

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Systemic Inflammation Response Index (SIRI)
Lasso di tempo: 24 hours after surgery

Systemic Inflammation Response Index (SIRI) is used as a composite marker of systemic inflammatory activation. It is calculated from peripheral venous blood samples using the formula:

SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count All parameters are obtained from routine complete blood count (CBC) analysis and expressed in ×10⁹/L.

SIRI reflects the interaction between innate immune activation (neutrophils and monocytes) and adaptive immune suppression (lymphocytes). Higher SIRI values indicate greater systemic inflammatory response.

24 hours after surgery
Systemic Inflammation Response Index (SIRI)
Lasso di tempo: 48 hours after surgery

Systemic Inflammation Response Index (SIRI) is used as a composite marker of systemic inflammatory activation. It is calculated from peripheral venous blood samples using the formula:

SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count All parameters are obtained from routine complete blood count (CBC) analysis and expressed in ×10⁹/L.

SIRI reflects the interaction between innate immune activation (neutrophils and monocytes) and adaptive immune suppression (lymphocytes). Higher SIRI values indicate greater systemic inflammatory response.

48 hours after surgery
Aggregate Index of Systemic Inflammation (AISI)
Lasso di tempo: 12 hours after surgery

Aggregate Index of Systemic Inflammation (AISI) is calculated as:

AISI = (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count All values are obtained from routine CBC and expressed in ×10⁹/L. AISI integrates neutrophils, monocytes, platelets, and lymphocytes, providing a broader assessment of systemic inflammatory and immune response compared to single ratios.

12 hours after surgery
Aggregate Index of Systemic Inflammation (AISI)
Lasso di tempo: 24 hours after surgery

Aggregate Index of Systemic Inflammation (AISI) is calculated as:

AISI = (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count All values are obtained from routine CBC and expressed in ×10⁹/L. AISI integrates neutrophils, monocytes, platelets, and lymphocytes, providing a broader assessment of systemic inflammatory and immune response compared to single ratios.

24 hours after surgery
Aggregate Index of Systemic Inflammation (AISI)
Lasso di tempo: 48 hours after surgery

Aggregate Index of Systemic Inflammation (AISI) is calculated as:

AISI = (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count All values are obtained from routine CBC and expressed in ×10⁹/L. AISI integrates neutrophils, monocytes, platelets, and lymphocytes, providing a broader assessment of systemic inflammatory and immune response compared to single ratios.

48 hours after surgery
Platelet Mass Index (PMI)
Lasso di tempo: 12 hours after surgery

Platelet Mass Index (PMI) reflects total circulating platelet mass and is calculated as:

PMI = Platelet count × Mean Platelet Volume (MPV) Platelet count is expressed in ×10⁹/L and MPV in femtoliters (fL). PMI reflects platelet activation and thrombo-inflammatory potential, which may increase in response to surgical stress.

12 hours after surgery
Platelet Mass Index (PMI)
Lasso di tempo: 24 hours after surgery

Platelet Mass Index (PMI) reflects total circulating platelet mass and is calculated as:

PMI = Platelet count × Mean Platelet Volume (MPV) Platelet count is expressed in ×10⁹/L and MPV in femtoliters (fL). PMI reflects platelet activation and thrombo-inflammatory potential, which may increase in response to surgical stress.

24 hours after surgery
Platelet Mass Index (PMI)
Lasso di tempo: 48 hours after surgery

Platelet Mass Index (PMI) reflects total circulating platelet mass and is calculated as:

PMI = Platelet count × Mean Platelet Volume (MPV) Platelet count is expressed in ×10⁹/L and MPV in femtoliters (fL). PMI reflects platelet activation and thrombo-inflammatory potential, which may increase in response to surgical stress.

48 hours after surgery
C-reactive Protein (CRP) Concentration
Lasso di tempo: 12 hours after surgery

C-reactive protein (CRP) is a laboratory marker of acute systemic inflammation measured in peripheral venous blood samples.

CRP concentration is expressed in mg/L and determined using standard hospital laboratory methods.

Higher CRP values indicate greater postoperative inflammatory response.

12 hours after surgery
C-reactive Protein (CRP) Concentration
Lasso di tempo: 24 hours after surgery

C-reactive protein (CRP) is a laboratory marker of acute systemic inflammation measured in peripheral venous blood samples.

CRP concentration is expressed in mg/L and determined using standard hospital laboratory methods.

Higher CRP values indicate greater postoperative inflammatory response.

24 hours after surgery
C-reactive Protein (CRP) Concentration
Lasso di tempo: 48 hours after surgery

C-reactive protein (CRP) is a laboratory marker of acute systemic inflammation measured in peripheral venous blood samples.

CRP concentration is expressed in mg/L and determined using standard hospital laboratory methods.

Higher CRP values indicate greater postoperative inflammatory response.

48 hours after surgery
Postoperative Pain Intensity (NRS)
Lasso di tempo: 4 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

4 hours after surgery
Postoperative Pain Intensity (NRS)
Lasso di tempo: 8 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

8 hours after surgery
Postoperative Pain Intensity (NRS)
Lasso di tempo: 12 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

12 hours after surgery
Postoperative Pain Intensity (NRS)
Lasso di tempo: 24 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

24 hours after surgery
Postoperative Pain Intensity (NRS)
Lasso di tempo: 48 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

48 hours after surgery
Opioid Consumption
Lasso di tempo: 48 hours after surgery

Total opioid consumption within the first 48 hours after surgery will be recorded.

All administered opioids will be converted to intravenous morphine milligram equivalents (MME) for standardization.

Higher cumulative MME indicates greater analgesic requirement.

48 hours after surgery
Time to First Rescue Analgesia
Lasso di tempo: 48 hours after surgery

Time from completion of surgery to first administration of rescue opioid analgesia.

Measured in minutes. Shorter time indicates earlier breakthrough pain.

48 hours after surgery

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 marzo 2026

Completamento primario (Effettivo)

30 settembre 2026

Completamento dello studio (Effettivo)

2 ottobre 2026

Date di iscrizione allo studio

Primo inviato

27 febbraio 2026

Primo inviato che soddisfa i criteri di controllo qualità

27 febbraio 2026

Primo Inserito (Effettivo)

4 marzo 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

6 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

3 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

De-identified individual participant data (IPD) underlying the results reported in publications (including demographic data, laboratory inflammatory indices such as SII, SIRI, AISI, CRP values, pain scores, opioid consumption, and time-to-event outcomes) will be made available to qualified researchers.

Data will be shared after removal of all direct identifiers in accordance with GDPR regulations and institutional data protection policies.

The study protocol, statistical analysis plan (SAP), and analytic code will also be available upon reasonable request.

Data will be provided for the purpose of secondary analyses, meta-analyses, or validation studies, subject to approval by the principal investigator and institutional review board, where applicable.

Periodo di condivisione IPD

Data will become available 6 months after publication of the primary results and will remain available for 5 years.

Criteri di accesso alla condivisione IPD

Access will be granted to researchers who provide:

A methodologically sound research proposal Institutional affiliation Ethical approval (if required) A signed data use agreement Requests should be directed to the principal investigator via institutional email.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA
  • CODICE_ANALITICO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi